Total Payments
$10,810
2024 Payments
$1,174
Companies
30
Transactions
317
Medicare Patients
647
Medicare Billing
$103,364
Payment Breakdown by Category
Food & Beverage$7,693 (71.2%)
Other$3,050 (28.2%)
Education$66.99 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,693 | 313 | 71.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,050 | 2 | 28.2% |
| Education | $66.99 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $3,322 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,354 | 65 | $0 (2024) |
| GENZYME CORPORATION | $1,280 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $866.79 | 31 | $0 (2024) |
| ALK-Abello, Inc | $658.84 | 12 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $520.90 | 30 | $0 (2024) |
| Genentech USA, Inc. | $414.72 | 14 | $0 (2024) |
| kaleo, Inc. | $395.06 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $357.88 | 24 | $0 (2024) |
| Shire North American Group Inc | $301.83 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,174 | 48 | GENZYME CORPORATION ($264.48) |
| 2023 | $1,465 | 56 | GENZYME CORPORATION ($386.20) |
| 2022 | $1,051 | 45 | ALK-Abello, Inc ($168.67) |
| 2021 | $2,762 | 55 | PFIZER INC. ($1,556) |
| 2020 | $2,407 | 45 | PFIZER INC. ($1,569) |
| 2019 | $1,319 | 57 | AstraZeneca Pharmaceuticals LP ($310.12) |
| 2018 | $508.34 | 10 | GlaxoSmithKline, LLC. ($163.47) |
| 2017 | $124.34 | 1 | Genentech USA, Inc. ($124.34) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Respiratory | ||||||
| 12/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | Food and Beverage | Cash or cash equivalent | $30.88 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Immunology | ||||||
| 08/26/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Allergy | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Immunology | ||||||
| 06/13/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Allergy | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 209 | 4,166 | $91,951 | $31,559 |
| 2022 | 5 | 169 | 3,085 | $75,157 | $26,895 |
| 2021 | 6 | 168 | 3,578 | $78,100 | $29,056 |
| 2020 | 5 | 101 | 2,215 | $45,669 | $15,854 |
Total Patients
647
Total Services
13,044
Medicare Billing
$103,364
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 59 | 3,728 | $55,920 | $15,669 | 28.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $10,400 | $5,401 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $10,080 | $4,073 | 40.4% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 22 | 305 | $5,490 | $2,491 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $4,050 | $1,839 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 23 | $4,991 | $1,820 | 36.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 12 | $1,020 | $265.81 | 26.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 56 | 2,958 | $44,370 | $13,007 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $9,800 | $5,130 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $9,720 | $4,179 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 25 | $5,625 | $2,633 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 26 | $5,642 | $1,947 | 34.5% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 48 | 3,134 | $47,010 | $14,240 | 30.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 48 | 48 | $9,600 | $5,116 | 53.3% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 21 | 334 | $6,012 | $3,024 | 50.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $6,480 | $2,820 | 43.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 29 | $5,623 | $2,425 | 43.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 15 | $3,375 | $1,431 | 42.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 30 | 1,927 | $28,905 | $8,637 | 29.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 27 | 27 | $5,400 | $2,794 | 51.7% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2020 | 14 | 228 | $4,104 | $1,890 | 46.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 22 | $3,300 | $1,363 | 41.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,960 | $1,170 | 29.6% |
About Dr. Gregory Rosner, M.D
Dr. Gregory Rosner, M.D is a Allergy & Immunology healthcare provider based in Purchase, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1346686904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Rosner, M.D has received a total of $10,810 in payments from pharmaceutical and medical device companies, with $1,174 received in 2024. These payments were reported across 317 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,693).
As a Medicare-enrolled provider, Rosner has provided services to 647 Medicare beneficiaries, totaling 13,044 services with total Medicare billing of $103,364. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Student in an Organized Health Care Education/Training Program, Allergy & Immunology
- Location Purchase, NY
- Active Since 05/22/2013
- Last Updated 04/04/2019
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1346686904
Products in Payments
- EUCRISA (Drug) $3,322
- DUPIXENT (Biological) $1,495
- NUCALA (Biological) $866.79
- FASENRA (Biological) $464.60
- Xolair (Biological) $414.72
- AUVI-Q (Drug) $395.06
- CUVITRU (Biological) $388.57
- FASENRA (Drug) $351.90
- XOLAIR (Drug) $307.92
- TEZSPIRE (Biological) $261.34
- XOLAIR (Biological) $212.98
- Xhance (Drug) $205.17
- DUPIXENT (Drug) $204.78
- Odactra (Drug) $204.70
- BEVESPI AEROSPHERE (Drug) $135.26
- ORLADEYO (Drug) $125.00
- STRATTICE (Device) $124.96
- CINRYZE (Drug) $121.87
- Ragwitek (Drug) $75.00
- Hizentra (Biological) $70.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.